| AKR1C3 | Aldo-Keto Reductase Family 1 Member C3 |
| PCa | prostate cancer |
| CRPC | castration-resistant prostate cancer |
| HNPC | hormone-naïve prostate cancer |
| ADT | androgen deprivation therapy |
| T | testosterone |
| DHT | 5α-dihydrotestosterone |
| AR | androgen receptor |
| DHEA | dehydroepiandrosterone |
| ER | estrogen receptor |
| PG | prostaglandin |
| TMA | tissue-microarray |
| RP | radical prostatectomy |
| TUR-P | transurethral resection of the prostate |
| PFS | progression-free survival |
| TS | total score |
| IS | intensity score |
| PS | proportion score |
| GS | Gleason score |
| CAB | combined androgen blockade |
| DOC | docetaxel |
| Abi | abiraterone |
| Enz | enzalutamide |
| LHRH | luteinizing hormone-releasing hormone |
| ARATs | androgen receptor-axis-targeted agents |
| GABAAR | gamma-aminobutyric acid type A receptor |